Francis Medical, Inc., a privately held medical device company based in Maple Grove, Minn., today announced that Aaron ...

Artera has secured CE marking under the European Union In Vitro Diagnostic Regulation (EU IVDR) for its ArteraAI prostate ...

An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

A study prospectively evaluated functional outcomes in men with prostate cancer managed with active surveillance, surgery with or without nerve sparing, or radiation.

The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023.  The ...

Erectile dysfunction treatment has long relied on self-reporting and a narrow set of treatment options. Advances support an ...

Dual regulatory milestones establish Artera as a global AI leader in precision oncologySAN FRANCISCO--(BUSINESS WIRE)--Artera, a developer of multimodal AI-based prognostic and predictive cancer tests ...

The Altaviva device was recently named a 2026 Edison Award winner in the Health, Medical and Biotech category. NORTHAMPTON, MA / ACCESS Newswire / April 21, 2026 / When Sarah Tapani sat in on one of t ...

A joystick-like robot lets Emory doctors guide a tiny wire to blocked blood vessels, offering precise, minimally invasive ...

Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company developing first-in-class therapies for cancer, autoimmune, and neuroimmune diseases, today announced the appointment of M ...

Explore how medical robots and healthcare robotics enhance surgery, diagnostics, and hospital workflows, highlighting key ...

The rise of a new generation of radiotherapies means we will soon need much greater quantities of radioactive atoms. That's ...